Try our Advanced Search for more refined results
October 18, 2017
Juno Therapeutics, Inc. et al v. Kite Pharma, Inc.
Case Number:
2:17-cv-07639
Court:
Nature of Suit:
Judge:
Firms
- Cooley LLP
- Fish & Richardson
- Gibson Dunn
- Irell & Manella
- Jones Day
- King & Spalding
- Kirkland & Ellis
- Milbank LLP
- Morrison Foerster
- Munger Tolles
- Orrick Herrington
Companies
- Bristol-Myers Squibb Co.
- Juno Therapeutics Inc.
- Kite Pharma Inc.
- Memorial Sloan Kettering Cancer Center
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 08, 2020
Juno Awarded Over $1.1B In Final Judgment For IP Case
A California federal judge on Wednesday entered final judgment awarding Juno Therapeutics and Sloan Kettering enhanced damages of over $389 million while boosting the total award to over $1.1 billion after a jury found that Kite Pharma willfully infringed a patent for a cancer immunotherapy.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login